Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

376
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
376

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[On the occasion of Professor Enno Christophers's 90th birthday].

Dermatologie (Heidelberg, Germany)·2026
Same author

Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Acceptability and perceived benefits of validated pruritus assessment instruments in the dermatological office and clinic: The perspectives of patients and physicians.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Medical rehabilitation in dermatology : Goals, program content, and application process].

Dermatologie (Heidelberg, Germany)·2024
Same author

Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Measuring well-being in psoriasis: psychometric properties of the WHO-5 questionnaire.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Related Experiment Video

Updated: Mar 18, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

[Pruritus in psoriasis : Profile and therapy].

A Tsianakas1, U Mrowietz2

  • 1Klinik für Hautkrankheiten, Universitätsklinikum Münster, Von-Esmarch-Str. 58, 48149, Münster, Deutschland. Athanasios.Tsianakas@ukmuenster.de.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|July 5, 2016
PubMed
Summary

Psoriasis commonly causes severe itching in most patients, significantly impacting quality of life. Research now recognizes pruritus as a key symptom, driving new treatment investigations.

Keywords:
AntidepressantsAntipsoriaticsNeurolepticsQuality of lifeSkin diseases

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

994
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

13.2K

Related Experiment Videos

Last Updated: Mar 18, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

994
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

13.2K

Area of Science:

  • Dermatology
  • Immunology
  • Neuroscience

Background:

  • Psoriasis is a prevalent chronic inflammatory skin condition.
  • Historically, pruritus (itching) was underestimated in psoriasis.
  • Recent data indicate 64-97% of psoriasis patients experience pruritus, often severe.

Purpose of the Study:

  • To highlight the significant role of pruritus in psoriasis.
  • To discuss the underlying mechanisms of psoriasis-induced pruritus.
  • To review current and emerging therapeutic strategies for pruritus in psoriasis.

Main Methods:

  • Review of current literature on psoriasis and pruritus.
  • Analysis of the role of neurogenic inflammation and neuropeptides (e.g., substance P, CGRP).
  • Examination of opioid receptor dysregulation (κ- and µ-opioid receptors) in lesional skin.

Main Results:

  • Pruritus is a highly prevalent and distressing symptom in psoriasis.
  • Neurogenic inflammation and neuropeptides contribute to pruritus.
  • Dysregulation of κ- and µ-opioid receptors in lesional skin favors pruritus.
  • Pruritus resolution correlates with psoriasis lesion clearance.

Conclusions:

  • Pruritus is a major symptom in psoriasis, significantly affecting quality of life.
  • Understanding neurogenic inflammation and opioid receptor balance is key to managing pruritus.
  • Targeted therapies (e.g., mirtazapine, pregabalin) can be used for severe pruritus.
  • Ongoing research and clinical trials are increasingly assessing pruritus in psoriasis treatment.